Althea Technologies, Inc., a leading provider of innovative technologies and services for pharmaceutical development and manufacturing has signed a Letter of Intent to establish a complementary commercialization partnership with Protein'eXpert.
Protein'eXpert is a Contract Research Organization devoted to recombinant protein engineering and production for biomedical research applications focusing on optimization of valuable target or therapeutic proteins. The agreement stems from the introduction of the firms through the Lyonbiopôle and Invest in France Agency initiatives in the United States.
The agreement provides for the pairing of each company's highly complementary expertise to better serve the growing biopharmaceutical development markets and extends the global commercial activities of each firm, particularly in Europe and the United States. Clients will gain access to Protein'eXpert's advanced protein engineering, process development and optimization expertise, with the full realm of cGMP manufacturing resources for production and Fill/Finish services from phase I clinical to commercial manufacturing provided by Althea. These complementary service offerings will allow both companies to reach larger markets, broaden services for new and challenging products and to better match early and late stage client requirements for protein projects.